Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/2/2018 |
| Start Date: | March 27, 2017 |
| End Date: | December 31, 2019 |
| Contact: | Paul Cinciripini |
| Email: | pcinciri@mdanderson.org |
| Phone: | 713-563-1264 |
Project Quitting Schedule
This trial studies how well a mobile smartphone application called Quitting Schedule works in
helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a
computer-based initiative that offered state of-the-art smoking cessation treatment and
counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for
non-patients to find information regarding smoking cessation advice and treatments. Quitting
Schedule may help participants to quit smoking.
helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a
computer-based initiative that offered state of-the-art smoking cessation treatment and
counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for
non-patients to find information regarding smoking cessation advice and treatments. Quitting
Schedule may help participants to quit smoking.
PRIMARY OBJECTIVES:
I. To adapt the internal algorithms of the scheduled reduced smoking approach in Computer
Assisted Stop Smoking Intervention for the World Wide Web (WebCASSI) into a smartphone
application (app): Quitting Schedule.
II. Once the smartphone app is developed, a pretesting phase with smoker seeking care at
MDACC Tobacco Treatment Program or another community service such as Equality Texas, Lesbian,
Gay, Bisexual, Transgender, and Queer (LGBTQ) Advisory Board of the City of Houston, Montrose
Center, Avenue 360 and Lesbian Health Initiative will follow.
III. To culturally and linguistically adapt Quitting Schedule app into Spanish language.
IV. To implement a feasibility trial in IDC (Colombia), INCan (Mexico), and INEN (Peru).
OUTLINE:
AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for
5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule.
AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.
I. To adapt the internal algorithms of the scheduled reduced smoking approach in Computer
Assisted Stop Smoking Intervention for the World Wide Web (WebCASSI) into a smartphone
application (app): Quitting Schedule.
II. Once the smartphone app is developed, a pretesting phase with smoker seeking care at
MDACC Tobacco Treatment Program or another community service such as Equality Texas, Lesbian,
Gay, Bisexual, Transgender, and Queer (LGBTQ) Advisory Board of the City of Houston, Montrose
Center, Avenue 360 and Lesbian Health Initiative will follow.
III. To culturally and linguistically adapt Quitting Schedule app into Spanish language.
IV. To implement a feasibility trial in IDC (Colombia), INCan (Mexico), and INEN (Peru).
OUTLINE:
AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for
5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule.
AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.
Inclusion Criteria:
- Current smokers (those who smoke at least 5 cigarettes a day; confirmed with carbon
monoxide (CO) levels equal or above 7 parts per million) newly enrolled in the Tobacco
Treatment Program at MDACC. (Aim 2)
- Adult cancer patients. (Aim 2)
- Current smokers seeking care at the Tobacco Treatment Program at MD Anderson and at
Houston area community services who have smoked at least 100 cigarettes in lifetime.
- Willing to download and use the app Quitting Schedule. (Aim 2)
- Willing to set a quit smoking date within 5 weeks of the enrollment. (Aim 2)
- Ownership of an iPhone or Android smartphone. (Aim 2)
Exclusion Criteria:
- Unwillingness to participate in the study. (Aim 2)
- Enrolled in another cessation program. (Aim 2)
- Current use of nicotine replacement (NRT) or other smoking cessation medications, e.g.
varenicline or bupropion outside of the MD Anderson Institution. (Aim 2)
- Expired CO levels below 7 parts per million (ppm). (Aim 2)
We found this trial at
1
site
Houston, Texas 77030
Principal Investigator: Paul Cinciripini
Phone: 713-563-1264
Click here to add this to my saved trials
